Gisev, N., Pearson, S. A., Dobbins, T., Currow, D. C., Blyth, F., Larney, S., Dunlop, A., Mattick, R. P., Wilson, A., & Degenhardt, L. (2018). Combating escalating harms associated with pharmaceutical opioid use in Australia: The POPPY II study protocol. BMJ Open, 8(12). doi:10.1136/bmjopen-2018-025840

Glantz, M., Moskalewicz, J., Caldas-de-Almeida, J., & Degenhardt, L. (2018). Alcohol-Use Disorders. In K. Scott, P. De Jonge, D. Stein, & R. Kessler (Eds.), Mental disorders around the world: Facts and figures from the WHO World Mental Health Surveys (pp. 223-242). Cambridge: Cambridge University Press. doi:10.1017/9781316336168.016

Grebely, J., Larney, S., Peacock, A., Colledge, S., Leung, J., Hickman, M., Vickerman, P., Blach, S., Cunningham, E., Dumchev, K., Lynskey, M., Stone, J., Trickey, A., Razavi, H., Mattick, R. P., Farrell, M., Dore, G. J., & Degenhardt, L. (2018). Global, regional, and country-level estimates of hepatitis C infection among people who have recently injected drugs. Addiction, Advance online publication. doi: 10.111/add.14393

Griffiths, S., Jacka, B., Degenhardt, L., Murray, S. B., & Larance, B. (2018). Physical appearance concerns are uniquely associated with the severity of steroid dependence and depression in anabolic-androgenic steroid users. Drug and Alcohol Review, 37 (5), 664-670. doi:10.1111/dar.12688

Grigg, J., Barratt, M. J., & Lenton, S. (2018). Double dropping down under: Correlates of simultaneous consumption of two ecstasy pills in a sample of Australian outdoor music festival attendees. Drug and Alcohol Review, 37(7), 851-855. doi:10.1111/dar.12843

Grigg, J., Barratt, M. J., & Lenton, S. (2018). Drug detection dogs at Australian outdoor music festivals: Deterrent, detection and iatrogenic effects. International Journal of Drug Policy, 60, 89-95. doi:10.1016/j.drugpo.2018.08.002

Hall, W., & Farrell, M. (2018). Prisoners and risk of injury after release. The Lancet Public Health, 3(5), e209-e210. doi:10.1016/S2468-2667(18)30073-2

Herzog, S., Shanahan, M., Grimison, P., Tran, A., Wong, N., Lintzeris, N., Simes, J., Stockler, M., & Morton, R. L. (2018). Systematic review of the costs and benefits of prescribed cannabis-based medicines for the management of chronic illness: Lessons from multiple sclerosis. PharmacoEconomics, 36(1), 67-78. doi:10.1007/s40273-017-0565-6

Hobden, B., Bryant, J., Carey, M., Baker, A. L., Farrell, M., Oldmeadow, C., Mattick, R.P., Shakeshaft, A., & Sanson-Fisher, R. (2018). Finding the optimal treatment model: A systematic review of treatment for co-occurring alcohol misuse and depression. Australian and New Zealand Journal of Psychiatry, 52(8), 737-750. doi:10.1177/0004867418758922

Howard, J. (2018). Cannabis-use among secondary school students in Pacific Island Countries and Territories: brief intervention guidance for school counsellors, nurses and primary health care workers and counsellors. Fiji Journal of Public Health, 7 (1), 18-21. Retrieved from: http://www.health.gov.fj/pdfs/Fiji%20Journal%20of%20Public%20Health%20Vol7Issue1.pdf Report

Hughes, C., & Ritter, C. (2018). What does the research evidence tell us about what Australians think about the legal status of drugs? A 2018 update. Bulletin No. 25- July 2018. Sydney, NSW: National Drug and Alcohol Research Centre, University of New South Wales. Retrieved from https://ndarc.med.unsw.edu.au/resource/what-does-research-evidence-tell-us-about-what-australians-think-about-legal-status-drugs